3,722 reports of this reaction
3.1% of all INSULIN ASPART reports
#2 most reported adverse reaction
NAUSEA is the #2 most commonly reported adverse reaction for INSULIN ASPART, manufactured by Novo Nordisk. There are 3,722 FDA adverse event reports linking INSULIN ASPART to NAUSEA. This represents approximately 3.1% of all 120,218 adverse event reports for this drug.
Patients taking INSULIN ASPART who experience nausea should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
NAUSEA is moderately reported among INSULIN ASPART users, representing a notable but not dominant share of adverse events.
In addition to nausea, the following adverse reactions have been reported for INSULIN ASPART:
The following drugs have also been linked to nausea in FDA adverse event reports:
NAUSEA has been reported as an adverse event in 3,722 FDA reports for INSULIN ASPART. This does not prove causation, but indicates an association observed in post-market surveillance data.
NAUSEA accounts for approximately 3.1% of all adverse event reports for INSULIN ASPART, making it one of the most commonly reported side effect.
If you experience nausea while taking INSULIN ASPART, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.